title: Effects of anagrelide on platelet factor 4 and vascular endothelial growth factor levels in patients with essential thrombocythemia.
authors.forename: Rossella R
authors.initials: RR
authors.lastname: Cacciola
authors.forename: Ernesto Di
authors.initials: ED
authors.lastname: Francesco
authors.forename: Rosario
authors.initials: R
authors.lastname: Giustolisi
authors.forename: Emma
authors.initials: E
authors.lastname: Cacciola
mesh_terms: D000328:Adult; D001792:Blood Platelets / Q000187:drug effects; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D010978:Platelet Factor 4 / Q000187:drug effects* / Q000378:metabolism; D011799:Quinazolines / Q000627:therapeutic use*; D013920:Thrombocythemia, Essential / Q000097:blood / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A / Q000097:blood / Q000187:drug effects*
chemical_list: D010975:Platelet Aggregation Inhibitors; D011799:Quinazolines; D042461:Vascular Endothelial Growth Factor A; D010978:Platelet Factor 4; C021139:anagrelide